The healthcare sector has seen big gains this year. The XLV is up about 20%. We've heard repeatedly from the GOP and President Trump that tax reform and regulatory rollbacks will help smaller companies. Are more gains ahead? Phil Chan is the CEO of Nasdaq listed medical device maker CytoSorbents joins us to discuss.